The Botswana Vaccine Institute (BVI) is a veterinary research institute owned by the Botswana government that carries out research on communicable diseases in domestic animals, with emphasis on viral transmitted infections. BVI manufactures vaccines against major animal diseases for use in Botswana and for sale in 16 African and Middle Eastern countries. BVI is a "leader in the research, manufacture and supply of livestock vaccines".[1]
| BVI | |
| Veterinary Research Institute overview | |
|---|---|
| Formed | 1978 |
| Type | Veterinary Research Institute |
| Jurisdiction | Government of Botswana |
| Headquarters | Broadhurst Industrial Park, 6385/6390 Lejara Road, Gaborone, Botswana |
| Veterinary Research Institute executives | |
| Website | Homepage |
Location edit
The headquarters and main offices of BVI are located in Broadhurst Industrial Park, 6385/90 Lejara Road, in the city of Gaborone, the capital of Botswana.[2]
Overview edit
BVI was founded in 1978. In 1979 the institution was registered as Botswana Vaccine Institute Limited, a self-funding company wholly owned by the government of Botswana. Over time, BVI forged a partnership with Merial, the French pharmaceutical conglomerate. Starting with vaccines against FMD, the institute has diversified into the research and manufacture of vaccines against anthrax, Contagious bovine pleuropneumonia, Ovine rinderpest, black quarter disease and rabies. The institute is an international reference laboratory on FMD.[1][3][4][5]
Developments edit
In February 2024, BVI and the Uganda Ministry of Agriculture, Animal Industry and Fisheries, began collaboration to manufacture a type-specific vaccine for FMD suitable for Uganda, for control of the disease and the prevention of future outbreaks.[6]
See also edit
References edit
- ^ a b Devex (22 February 2024). "About Botswana Vaccine Institute". Devex.com. Retrieved 22 February 2024.
- ^ BVI (22 February 2024). "Physical Address of Botswana Vaccine Institute". Botswana Vaccine Institute (BVI). Gaborone, Botswana. Retrieved 22 February 2024.
- ^ WOAH (4 November 2011). "New FMD vaccine launch BVI". World Organisation for Animal Health (WOAH). Paris, France. Retrieved 22 February 2024.
- ^ Pauline Dikuelo (16 August 2022). "BVI diversifies product offering". Mmegi Online. Gaborone, Botswana. Retrieved 22 February 2024.
- ^ J. Falconer & J. J. Guinet (1985). "Botswana Vaccine Institute — Future Regional Laboratory for Rabies Vaccine Production". Rabies in the Tropics. Springer, Berlin, Heidelberg. pp. 679–682. doi:10.1007/978-3-642-70060-6_90. ISBN 978-3-540-13826-6. Retrieved 22 February 2024.
- ^ Tonny Abet (21 February 2024). "Uganda, Botswana join hands in search for FMD vaccine". Daily Monitor. Kampala, Uganda. Retrieved 22 February 2024.
External links edit
- Official website
- BVI'S P300 million booster As of 27 August 2022.